跳至主要内容
临床试验/CTRI/2019/10/021788
CTRI/2019/10/021788招募中未知

Autologous platelet derived growth factor concentrate aka Autologous Blood Cell Derivative (ABCD) therapy for the treatment of thin endometrium.

Seragen Biotherapeutics private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Thin endometrium, Two failed implantation in previous IVF cycles

排除标准

  • Patient on hormone therapy, Diagnosis of cancer or Chemotherapy treatments,Abnormal platelet function, Previous Incision in the uterus,
  • Endocrine abnormalities such as hyperprolactinemia or abnormal thyroid functions, Systemic use of corticosteroids two weeks before the procedure,Serious, pre-existing medical conditions such as bleeding disorders, septicemia, TB, Acute and chronic infections,Severe metabolic and systemic disorders,Chronic Liver Pathology,Anti-coagulation therapy

研究者

发起方
Seragen Biotherapeutics private Limited

相似试验